Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of other drugs on Descartes-08
1 evidence topic · 1 source
Consistent product lots across participants with differing treatment histories: phase 2b
“Despite patients with diversity in antibody serotype and treatment history (see companion paper6), all analyzed lots (n = 35 of 36 patients randomized) exhibited consistent characteristics with favorable viability, CD8+ cell frequencies and CAR expression (Fig. 2b–d).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote